Recordati Polska > Home

RECORDATI POLSKA Sp. z.o.o - Poland

Recordati offers a wide range of innovative medicines, mainly for cardiovascular and urological disorders, and unique treatments for rare diseases.

Dedicated to treating the most vulnerable. Recordati Rare Diseases, the Recordati company dedicated to treatments for rare diseases.

We are also present in the self-medication segment and have always been committed to the improvement of quality of life by offering succesful products with well-known brands.

New products, new clinical trials, new projects in new therapeutic areas: these are Recordati's commitments and are a fundamental premise for its growth.

Recordati is a respected international pharmaceutical group and partner of important companies. >>

Each person with a rare disease has the right to the best treatment. >>

Research & Development

With an eye on the future the Recordati group invests significantly in research and development. >>

International Presence

Towards a global presence, a strategy of international development. >>

Committed to generating future value by enacting an intelligent partnering policy. >>

Share Price - Investors

“The most valuable currency in financial markets is reliable information”. (Michael Bloomberg, Mary Shapiro) >>
>>

Polski | English

Company data

Recordati Polska sp. z o.o. Al. Armii Ludowej 26
00-609 Warszawa
Tel: +48 22 206 84 50
NIP: 9451933649
KRS: 0000099901
Follow us

Employer’s Profile

Odwiedź nasz Profil Pracodawcy

Privacy Policy

Prizes and awards

Gazele Biznesu